3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
21
OTHER_GOV
1
NIH
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Carcinoma, Non-Small-Cell Lung
927
Neoplasms
612
Breast Neoplasms
611
Colorectal Neoplasms
458
Neoplasm Metastasis
398
Ovarian Neoplasms
333
Prostatic Neoplasms
316
Melanoma
316
Lung Neoplasms
294
Multiple Myeloma
293
Recurrence
281
Squamous Cell Carcinoma of Head and Neck
248
Stomach Neoplasms
232
Pancreatic Neoplasms
231
Leukemia, Myeloid, Acute
224
Triple Negative Breast Neoplasms
193
Endometrial Neoplasms
190
Carcinoma, Renal Cell
183
Lymphoma, Non-Hodgkin
178
Carcinoma, Hepatocellular
178
Small Cell Lung Carcinoma
166
Leukemia, Lymphocytic, Chronic, B-Cell
158
Advanced Solid Tumors
158
Lymphoma, Follicular
150
Lymphoma, Large B-Cell, Diffuse
141
Urinary Bladder Neoplasms
140
Lymphoma
138
Advanced Solid Tumor
137
Uterine Cervical Neoplasms
136
Head and Neck Neoplasms
134
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Monoclonal Gammopathy of Undetermined Significance
×
1 year
×
Clear all
NCT06140524
2026-06-04
LINKER-MGUS1
Regeneron Pharmaceuticals
Phase 2
Recruiting
116 enrolled